| Report Title | Price | Action |
|---|---|---|
| Retinoid X Receptor (RXR) - Drugs in Development, 2021
Retinoid X Receptor (RXR) - Drugs in Development, 2021 Summary Retinoid X Receptor (RXR) - Drugs in Development, 2021 provides in depth analysis on ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021
Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021 Summary Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Smoking Cessation (Central Nervous System) - Drugs in Development, 2021
Smoking Cessation (Central Nervous System) - Drugs in Development, 2021 Summary Smoking Cessation (Central Nervous System) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021
Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021 Summary Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Interleukin 10 Receptor (IL10R) - Drugs in Development, 2021
Interleukin 10 Receptor (IL10R) - Drugs in Development, 2021 Summary Interleukin 10 Receptor (IL10R) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Tumor Necrosis Factor Ligand Superfamily Member 4 (Glycoprotein Gp34 or OX40 Ligand or TAX Transcriptionally Activated Glycoprotein 1 or CD252 or TNFSF4) - Drugs in Development, 2021
Tumor Necrosis Factor Ligand Superfamily Member 4 (Glycoprotein Gp34 or OX40 Ligand or TAX Transcriptionally Activated Glycoprotein 1 or CD252 or TNFS...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| RNA Polymerase I (RNAP I or Pol I or EC 2.7.7.6) - Drugs in Development, 2021
RNA Polymerase I (RNAP I or Pol I or EC 2.7.7.6) - Drugs in Development, 2021 Summary RNA Polymerase I (RNAP I or Pol I or EC 2.7.7.6) - Drugs in De...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Undisclosed (Undisclosed) - Drugs in Development, 2021
Undisclosed (Undisclosed) - Drugs in Development, 2021 Summary Undisclosed (Undisclosed) - Drugs in Development, 2021 provides an overview of the Un...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021
Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021 Summary Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 220
|
$ 2500 | |
| Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021
Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021 Summary Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021 provides an ov...
Published: Apr-2021 | No. of Pages: 210
|
$ 2500 | |
| Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) - Drugs in Development, 2021
Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) - Drugs in Development, 2021 Summary Interleukin 21 Receptor (Novel Interleuk...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) - Drugs in Development, 2021
Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) - Drugs in Development, 2021 Summary Semaphorin 3A (Semaphor...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Subarachnoid Hemorrhage (Cardiovascular) - Drugs in Development, 2021
Subarachnoid Hemorrhage (Cardiovascular) - Drugs in Development, 2021 Summary Subarachnoid Hemorrhage (Cardiovascular) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Spinal Stenosis (Central Nervous System) - Drugs in Development, 2021
Spinal Stenosis (Central Nervous System) - Drugs in Development, 2021 Summary Spinal Stenosis (Central Nervous System) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021
Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021 Summary Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 100
|
$ 2000 | |
| Interleukin 22 Receptor (IL22R) - Drugs in Development, 2021
Interleukin 22 Receptor (IL22R) - Drugs in Development, 2021 Summary Interleukin 22 Receptor (IL22R) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Serine/Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) - Drugs in Development, 2021
Serine/Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) - Drugs in Development, 2021 Summary Serine/Threonine Protein Kinase Pim (Pim...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Epileptic Encephalopathy (Central Nervous System) - Drugs in Development, 2021
Epileptic Encephalopathy (Central Nervous System) - Drugs in Development, 2021 Summary Epileptic Encephalopathy (Central Nervous System) - Drugs in ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Squamous Cell Carcinoma (Oncology) - Drugs in Development, 2021
Squamous Cell Carcinoma (Oncology) - Drugs in Development, 2021 Summary Squamous Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an ...
Published: Apr-2021 | No. of Pages: 150
|
$ 2000 | |
| Lung Disease (Respiratory) - Drugs in Development, 2021
Lung Disease (Respiratory) - Drugs in Development, 2021 Summary Lung Disease (Respiratory) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 85
|
$ 2000 |